• Dormakaba’s net sales rose 5.2% to CHF 702.9 million in its first quarter of 2026/27, ended September 30, 2026.
• Organic sales grew 4%, driven by price increases of 2.7% and volume growth of 1.3%.
• The 2026/27 outlook remains unchanged, targeting organic sales growth above 3% and an operating profit margin above 11%.
• Operating cash flow margin guidance remains 10.5%-11.5%.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. DORMAKABA Holding AG published the original content used to generate this news brief via EQS News (Ref. ID: adhoc_2423386_en) on October 28, 2026, and is solely responsible for the information contained therein.